NXGB

NxGen Brands Inc. NXGB

NXGB
NxGen Brands Inc. RSCI
Redwood Scientific Technologies, Inc. GENX
Genex Pharmaceutical, Inc. CANQF
CanaQuest Medical Corp. SYUP
Anbc, Inc. TBET
Tibet Pharmaceuticals, Inc. ETAOF
ETAO International Co., Ltd. FORU
ForU Holdings, Inc. BZAMF
BZAM Ltd. ULGX
Urologix, Inc.

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode NXGB RSCI GENX CANQF SYUP TBET ETAOF FORU BZAMF ULGX
6M -96.69 % -84.14 % 0.00 % -99.48 % 100.00 % 0.00 % 300.00 % 0.00 % 900.00 % 0.00 %
YTD 333.33 % -88.90 % 0.00 % -99.50 % -96.00 % 0.00 % 3 900.00 % 0.00 % 900.00 % 0.00 %
1Y 333.33 % -86.13 % 0.00 % -99.50 % -96.00 % 0.00 % 3 900.00 % 0.00 % 9 900.00 % 0.00 %
3Y -97.22 % 85.00 % 0.00 % -99.94 % -87.50 % 9 900.00 % -100.00 % 0.00 % -99.98 % 0.00 %
5Y -99.00 % -77.76 % -97.96 % -99.89 % -99.77 % 9 900.00 % -100.00 % -99.85 % -100.00 % -97.56 %
10Y -87.00 % -92.60 % -96.30 % -99.99 % -99.87 % 9 900.00 % -100.00 % -98.17 % -100.00 % -98.36 %
Depuis le début -100.00 % -92.60 % -99.84 % -99.99 % -99.75 % 9 900.00 % -100.00 % -100.00 % -100.00 % -100.00 %

Dividende